Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
106 pending office actions • 61 art units • 102 examiners • 0 of 106 (0%) have an AI response strategy ready • 76 patents granted in the last 365 days
Mayo Foundation for Medical Education and Research manages a company patent portfolio with 2 pending office actions. These matters are situated within the Biotechnology & Pharmaceuticals technology area. The portfolio's activity is concentrated within 1 distinct art unit and 2 distinct examiners.
DONOHUE, SEAN R is the busiest examiner, currently overseeing 1 pending office action. This means that the other pending office action is handled by a different distinct examiner. This distribution shows that each active matter for the company is being reviewed by a unique individual within the 1 distinct art unit.
For practitioners, the involvement of 2 distinct examiners across 2 pending office actions requires a separate strategy for each application. The concentration within 1 distinct art unit suggests that the Biotechnology & Pharmaceuticals technology being patented is focused in a specific technical field. Coordination between these examiners is possible given the shared art unit, but the 2 pending office actions still require a tailored approach to the specific requirements of each examiner.
Based on the USPTO statutory response window for each pending office action. 27 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 27 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 4 (4%) |
| §101 + other | 16 (15%) |
| §103 only | 26 (25%) |
| §102 only | 4 (4%) |
| §112 only | 5 (5%) |
| Double-patenting + other | 7 (7%) |
| Multi-statute (no §101) | 44 (42%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| STEELE, AMBER D | 2 | 58.8% | +9.4% |
| DRISCOLL, MAUREEN VARINA | 2 | 64.5% | +41.5% |
| HAN, SETH | 2 | 58.9% | +27.0% |
| MCGINNITY, JAMES RYAN | 2 | 60.3% | +49.8% |
| SHENG, CHAO | 1 | 64.6% | +26.8% |
| WAGGLE, JR, LARRY E | 1 | 80.6% | +17.3% |
| SOREY, ROBERT A | 1 | 49.3% | +45.3% |
| ERICKSON, BENNETT S | 1 | 38.7% | +45.5% |
| GHAND, JENNIFER LEIGH-STEWAR | 1 | 60.5% | +27.8% |
| CHOI, YOUNHEE JEON | 1 | 71.2% | +49.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17768537 | Bi-Peptide with Affinity to Extracellular Matrix Proteins or Cells and to Growth Factors for Tissue Healing and Regeneration | STEELE, AMBER D | 280d overdue |
| 18033903 | METHODS AND MATERIALS FOR IDENTIFYING AND TREATING MEMBRANOUS NEPHROPATHY | FERNANDEZ, SUSAN EMILY | 72d overdue |
| 18599917 | COGNITIVE FUNCTION IMPROVEMENTS AND BIOMARKER-MODULATED DEEP BRAIN STIMULATION | SKROBARCZYK III, ROBERT ANTHONY | 42d overdue |
| 17050885 | INTRACRANIAL ELECTRODE AND DELIVERY SYSTEM | GUERRERO ROSARIO, ANA VERUSKA | 30d overdue |
| 18020515 | PLASMA EXCHANGE REMOVAL OF SPD-L1 | SULLIVAN, DENNIS JOHN | 28d overdue |
| 18660908 | ELECTROPORATION FOR SELECTIVE GI TRACT DEPTH ABLATION AND REGENERATION FOR GI DISEASES | RHODES, NORA W | 18d overdue |
| 17271981 | METHODS OF DETERMINING TREATMENT CONSISTING OF RADIATION THERAPY AND/OR ALKYLATING CHEMOTHERAPY IN PATIENTS SUFFERING FROM CANCER | MCANANY, JOHN D | 18d overdue |
| 18574543 | System and Method for Non-Invasive Determination of Pressure in a Biological Compartment | BRUCE, FAROUK A | 11d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17802275 | MEDIASTINUM ACCESS DEVICES AND METHODS | MCGINNITY, JAMES RYAN | 4d overdue |
| 19055401 | CANNULA AND STYLET REVERSER | CHOI, YOUNHEE JEON | 5d |
| 17209160 | MATERIALS AND METHODS FOR TREATING CANCER | DRISCOLL, MAUREEN VARINA | 41d |
| 19399465 | NON-METALLIC ULTRASOUND-DETECTABLE MARKERS | SHENG, CHAO | — |
| 19384490 | Meta-Diaphyseal Cones for Revision Knee Arthroplasty | WAGGLE, JR, LARRY E | — |
| 19264243 | METHOD AND AN APPARATUS FOR DETECTING A LEVEL OF CARDIOVASCULAR DISEASE | SOREY, ROBERT A | — |
| 19136790 | SYSTEMS AND METHODS FOR PATIENT-SPECIFIC TREATMENT RECOMMENDATION OPTIMIZED WITH MULTISTAGE MACHINE LEARNING | ERICKSON, BENNETT S | — |
| 19104843 | EMBEDDED SEIZURE DETECTION DURING THERAPEUTIC BRAIN STIMULATION | GHAND, JENNIFER LEIGH-STEWAR | — |
| Art Unit | Apps |
|---|---|
| 3771 | 7 |
| 3794 | 5 |
| 3797 | 4 |
| 3781 | 4 |
| 1682 | 4 |
| 3791 | 4 |
| 3798 | 3 |
| 2672 | 3 |
| 3792 | 3 |
| 1642 | 3 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19399465 | NON-METALLIC ULTRASOUND-DETECTABLE MARKERS | SHENG, CHAO | 3797 | §103 | Non-Final OA | — | Pending | Nov 24, 2025 |
| 19384490 | Meta-Diaphyseal Cones for Revision Knee Arthroplasty | WAGGLE, JR, LARRY E | 3775 | §102§103 | Non-Final OA | — | Pending | Nov 10, 2025 |
| 19264243 | METHOD AND AN APPARATUS FOR DETECTING A LEVEL OF CARDIOVASCULAR DISEASE | SOREY, ROBERT A | 3682 | §101§103§112 | Non-Final OA | — | Pending | Jul 09, 2025 |
| 19136790 | SYSTEMS AND METHODS FOR PATIENT-SPECIFIC TREATMENT RECOMMENDATION OPTIMIZED WITH MULTISTAGE MACHINE LEARNING | ERICKSON, BENNETT S | 3683 | §101§103 | Non-Final OA | — | Pending | Jun 06, 2025 |
| 19104843 | EMBEDDED SEIZURE DETECTION DURING THERAPEUTIC BRAIN STIMULATION | GHAND, JENNIFER LEIGH-STEWAR | 3796 | §102§103 | Non-Final OA | — | Pending | Feb 19, 2025 |
| 19055401 | CANNULA AND STYLET REVERSER | CHOI, YOUNHEE JEON | 3797 | §102 | Final Rejection | 5d | Pending | Feb 17, 2025 |
| 19099889 | METHODS TO RECONSTRUCT 3D IMAGE/MAP FOR THE STIFFNESS OF SOFT TISSUES | SAKAMOTO, COLIN T | 3798 | §102§103§112 | Non-Final OA | — | Pending | Jan 30, 2025 |
| 18978181 | FOAMY VIRUSES AND METHODS OF USE | ZHU, JIANJIAN | 1631 | §112 | Non-Final OA | — | Pending | Dec 12, 2024 |
| 18873086 | Self-Trained Neural Network for Noise Reduction in Computed Tomography | BITAR, NANCY | 2664 | §103§112 | Non-Final OA | — | Pending | Dec 09, 2024 |
| 18971644 | MULTISCALE BRAIN ELECTRODE DEVICES AND METHODS FOR USING THE MULTISCALE BRAIN ELECTRODES | KIM, EUN HWA | 3794 | §102§103DP | Non-Final OA | — | Pending | Dec 06, 2024 |
| 18870941 | ESTIMATION OF VISCOELASTICITY OF ARTERIAL OR VENOUS WALL | DAVIS, AMELIE R | 3798 | §101§112 | Non-Final OA | — | Pending | Dec 02, 2024 |
| 18955380 | SPEECH ANALYSIS DEVICES AND METHODS FOR IDENTIFYING MIGRAINE ATTACKS | AGAHI, DARIOUSH | 2656 | §103Other | Non-Final OA | — | Pending | Nov 21, 2024 |
| 18942021 | MACHINE-LEARNING FOR PROCESSING LEAD-INVARIANT ELECTROCARDIOGRAM INPUTS | WEHRHEIM, LINDSEY GAIL | 3799 | §102 | Non-Final OA | — | Pending | Nov 08, 2024 |
| 18849016 | DEEP LEARNING-BASED MEDICAL IMAGE MOTION ARTIFACT CORRECTION | SETH, MANAV | 2672 | §102§103 | Non-Final OA | — | Pending | Sep 20, 2024 |
| 18849012 | Uncertainty Assessment of Medical Image Noise Reduction and Image Processing | NASHER, AHMED ABDULLALIM-M | 2675 | §102§103 | Non-Final OA | — | Pending | Sep 20, 2024 |
| 18848249 | METHODS AND MATERIALS FOR TREATING PANCREATIC DISEASES AND DISORDERS | SCHMITT, MICHAEL J | 1629 | §102 | Non-Final OA | — | Pending | Sep 18, 2024 |
| 18885624 | ECG-BASED CARDIAC EJECTION-FRACTION SCREENING | LUKJAN, SEBASTIAN X | 3792 | §103§112Other | Non-Final OA | — | Pending | Sep 14, 2024 |
| 18821111 | SYSTEM FOR DIAGNOSING, TRACKING, AND PREDICTING RECOVERY PATTERNS IN PATIENTS WITH TRAUMATIC BRAIN INJURY | BODENDORF, ANDREW | 3715 | §101§102§103 | Non-Final OA | — | Pending | Aug 30, 2024 |
| 18841466 | TISSUE DISPLACEMENT FOAM | LIPPERT, JOHN WILLIAM | 1615 | §103§112 | Non-Final OA | — | Pending | Aug 26, 2024 |
| 18815717 | COMPACT WHOLE SLIDE IMAGE REPRESENTATION LEARNING WITHOUT MEMORY BOTTLENECK | CHAN, CAROL WANG | 2672 | §102§103§112 | Non-Final OA | — | Pending | Aug 26, 2024 |
| 18811236 | DEVICES AND METHODS FOR TRANSVASCULAR DRAINAGE OF FLUIDS IN AN INTRACRANIAL EXTRAVASCULAR SPACE | MARCETICH, ADAM M | 3781 | §103 | Non-Final OA | — | Pending | Aug 21, 2024 |
| 18839187 | MULTI-MODE SOUND PERCEPTION HEARING STIMULUS SYSTEM AND METHOD | SNIEZEK, ANDREW L | 2693 | §102§103§112 | Non-Final OA | — | Pending | Aug 16, 2024 |
| 18834684 | METHODS AND MATERIALS FOR IDENTIFYING AND TREATING VACCINE-INDUCED IMMUNE THROMBOTIC THROMBOCYTOPENIA | COUNTS, GARY W | 1678 | §101§102§103§112 | Non-Final OA | — | Pending | Jul 31, 2024 |
| 18784215 | DEVICE, SYSTEM, AND METHOD FOR NEUROMODULATION | PRUITT, HALEY NICOLE | 3796 | §103 | Non-Final OA | — | Pending | Jul 25, 2024 |
| 18748403 | Methods and Materials for Using Measles Viruses | KINSEY WHITE, NICOLE ERIN | 1672 | §112DP | Non-Final OA | — | Pending | Jun 20, 2024 |
| 18746198 | DETECTING NEOPLASM | AEDER, SEAN E | 1642 | §101§112DP | Non-Final OA | — | Pending | Jun 18, 2024 |
| 18747024 | System and Method for High Fidelity Computed Tomography | GORADIA, SHEFALI DINESH | 2676 | §102§103 | Final Rejection | — | Pending | Jun 18, 2024 |
| 18744995 | DETECTION OF COLON NEOPLASIA BY ANALYSIS OF METHYLATED DNA | GREENE, CAROLYN LEE | 1681 | §101 | Non-Final OA | — | Pending | Jun 17, 2024 |
| 18720351 | System And Method For Securing Lines | SULLIVAN, MATTHEW J | 3677 | §102§103 | Final Rejection | — | Pending | Jun 14, 2024 |
| 18719045 | THERAPEUTIC SYSTEMS AND METHODS USING ELECTROPORATION | TEMPLETON, MARINA DELANEY | 3794 | §102§103 | Non-Final OA | — | Pending | Jun 12, 2024 |
| 18739135 | SMALL MOLECULE CD38 INHIBITORS AND METHODS OF USING SAME | HAVLIN, ROBERT H | 1626 | §103§112DP | Non-Final OA | — | Pending | Jun 10, 2024 |
| 18668093 | SYSTEMS AND METHODS FOR EXECUTIVE FUNCTION REHABILITATION | ALVESTEFFER, STEPHEN D | 3715 | §101§103 | Non-Final OA | 10d overdue | Pending | May 17, 2024 |
| 18660908 | ELECTROPORATION FOR SELECTIVE GI TRACT DEPTH ABLATION AND REGENERATION FOR GI DISEASES | RHODES, NORA W | 3794 | §102§103§112 | Final Rejection | 18d overdue | Pending | May 10, 2024 |
| 18705695 | COMPOSITIONS AND METHODS FOR DETECTING OROPHARYNGEAL CANCER | WOOLWINE, SAMUEL C | 1637 | §102§103§112 | Non-Final OA | — | Pending | Apr 29, 2024 |
| 18631941 | SYNERGISTIC DRUG COMBINATIONS TO TREAT CANCER | ARCORIA, PAUL JOSEPH | 1623 | §102§103 | Non-Final OA | — | Pending | Apr 10, 2024 |
| 18628011 | DIGITAL SEQUENCE ANALYSIS OF DNA METHYLATION | HANEY, AMANDA MARIE | 1682 | §102§103 | Non-Final OA | — | Pending | Apr 05, 2024 |
| 18698764 | CELL ISOLATION AND REAGENT EXCHANGE IN A MICROFLUIDIC DEVICE | XU, XIAOYUN | 1797 | §103 | Non-Final OA | — | Pending | Apr 04, 2024 |
| 18615855 | Whole-Slide Image Classification and Gene Profile Prediction Using Machine Learning | SORRIN, AARON JOSEPH | 2672 | §102§103§112 | Non-Final OA | — | Pending | Mar 25, 2024 |
| 18692467 | METHODS AND MATERIALS FOR ASSESSING AND TREATING ORAL LICHEN PLANUS | SWITZER, JULIET CAROLINE | 1682 | §101§103 | Non-Final OA | — | Pending | Mar 15, 2024 |
| 18599917 | COGNITIVE FUNCTION IMPROVEMENTS AND BIOMARKER-MODULATED DEEP BRAIN STIMULATION | SKROBARCZYK III, ROBERT ANTHONY | 3700 | §102§103§112 | Final Rejection | 42d overdue | Pending | Mar 08, 2024 |
| 18685847 | Systems and Methods for Predicting Corneal Improvement From Scheimpflug Imaging Using Machine Learning | BILODEAU, DUSTIN E | 2664 | §103 | Final Rejection | — | Pending | Feb 22, 2024 |
| 18442934 | COSTIMULATORY B7-H1 IN RENAL CELL CARCINOMA PATIENTS: INDICATOR OF TUMOR AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET | IVICH, FERNANDO NMN | 1678 | §101DP | Non-Final OA | — | Pending | Feb 15, 2024 |
| 18683697 | TREATING CANCER | MOORE, JOHN DAVID | 1638 | §103 | Non-Final OA | — | Pending | Feb 14, 2024 |
| 18681926 | MYECTOMY DEVICES AND METHODS | SHI, KATHERINE MENGLIN | 3771 | §102§103§112 | Final Rejection | 21d | Pending | Feb 07, 2024 |
| 18294747 | ASSESSING AND TREATING MESOTHELIOMA | LEE, YIE CHIA | 1642 | §103§112 | Non-Final OA | — | Pending | Feb 02, 2024 |
| 18405331 | COMPOSITIONS COMPRISING A VAGINAL MOLD AND METHODS OF USE THEREOF | LONG, SARAH A | 3771 | §103 | Final Rejection | — | Pending | Jan 05, 2024 |
| 18404131 | MANP Analogues | STEELE, AMBER D | 1658 | §102§103§112DP | Non-Final OA | — | Pending | Jan 04, 2024 |
| 18574543 | System and Method for Non-Invasive Determination of Pressure in a Biological Compartment | BRUCE, FAROUK A | 3797 | §101§103 | Non-Final OA | 11d overdue | Pending | Dec 27, 2023 |
| 18542354 | System and Method for Carbon Particle Therapy for Treatment of Cardiac Arrhythmias and Other Diseases | CASLER, BRIAN L | 3791 | §102§103DP | Non-Final OA | — | Pending | Dec 15, 2023 |
| 18533857 | SYSTEMS FOR AUTOMATED CONTROL OF FLUIDIC DEVICES AND METHODS THEREOF | WALLENHORST, MAUREEN | 1797 | §103§112 | Non-Final OA | — | Pending | Dec 08, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMayo Foundation for Medical Education and Research has 106 pending office actions as of October 2026, spread across 61 art units and 102 examiners.
Amber D Steele has the most, with 2 of Mayo Foundation for Medical Education and Research's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.